Latest News - National Psoriasis Foundation

Tuesday, December 04, 2018

New PsA Guidelines from National Psoriasis and Rheumatology Orgs Recommend Treat-to-Target Approach

Newly released psoriatic Arthritis (PsA) treatment guidelines from the National Psoriasis Foundation (NPF) and the American College of Rheumatology (ACR) are calling for a treat-to-target approac…

Read the full story

Thursday, May 24, 2018

Psoriatic Arthritis Awareness Project Launches

In recognition of Psoriatic Arthritis Action Month, the National Psoriasis Foundation (NPF), in collaboration with Novartis Pharmaceuticals Corporation, has premiered the Psoriatic Arthritis (PsA) Awa…

Read the full story

Tuesday, May 15, 2018

National Psoriasis Foundation Honors Dr. Jerry Bagel with Excellence in Leadership Award

Jerry Bagel, MD, an internationally recognized expert in the treatment of psoriasis and founder of Windsor Dermatology and Psoriasis Treatment Center of Central New Jersey, will receive the Excellence…

Read the full story

Friday, December 15, 2017

NPF Launches New Resource for Youth with Psoriasis, Psoriatic Arthritis

Our Spot, a new resource launched by The National Psoriasis Foundation (NPF),  provides resources for kids and teens living with psoriasis and psoriatic arthritis. The program includes a web…

Read the full story

Friday, August 25, 2017

National Psoriasis Foundation Honors Research Award Recipients at Biennial Research Symposium

The National Psoriasis Foundation (NPF) recognized two distinguished research professionals for their unique impact on psoriatic disease research during the 2017 NPF Research Symposium. The NPF Med…

Read the full story

Friday, December 30, 2016

National Psoriasis Foundation Awards 2016 Grants and Fellowships

The National Psoriasis Foundation (NPF) awarded more than $1.9 million in research funding in 2016, including 23 new projects from around the world. Established and emerging scientists recei…

Read the full story

Thursday, November 10, 2016

NPF Offers Open Enrollment Insurance Advice Via New Patient Navigation Center

The National Psoriasis Foundation (NPF) Patient Navigation Center aims to help patients learn more about psoriatic disease, how to manage their condition and get answers to specific insurance and acce…

Read the full story

Tuesday, October 18, 2016

Biosim Update: Pfizer to Begin Shipping INFLECTRA in Late November 2016

Pfizer Inc. will begin shipment of INFLECTRA (infliximab-dyyb) for injection, a biosimilar of REMICADE1 (infliximab) to wholesalers in the United States in late November 2016. INFLECTRA will be the…

Read the full story

Thursday, September 15, 2016

Save the Date: Sept 28th Marks First Ever PsA Awareness Day

September 28th marks the first-ever Psoriatic Arthritis (PsA) Awareness Day. Launched by Celgene Corporation and the National Psoriasis Foundation (NPF), PsA Awareness Day is dedicated to education…

Read the full story

Wednesday, June 29, 2016

Global Psoriasis Survey: 85% of US Respondents Faced Social Stigma Because of Psoriasis

Novartis released new results from its Clear About Psoriasis Survey, the largest global survey to date of people with moderate-to-severe psoriasis. Findings reveal 85 percent of US respondents have su…

Read the full story

Wednesday, June 29, 2016

Laser Procedures Seem Generally OK for Psoriasis Patients: Analysis

Patients with psoriasis who undergo laser procedures do not appear to be at risk for koebnerization, according to research published this spring in Dermatologic Surgery and recently reported by t…

Read the full story

Tuesday, May 03, 2016

Lilly’s Taltz Now Available for Psoriasis

Eli Lilly and Company's Taltz (ixekizumab) injection 80 mg/mL for the treatment of moderate-to-severe plaque psoriasis is now available by prescription order through a contracted network of specia…

Read the full story

Monday, May 02, 2016

Largest Independent US Psoriasis Registry to Track Safety of Ixekizumab Biologic Treatment

The Corrona Psoriasis Registry will track the drug safety reporting for ixekizumab, Eli Lilly and Company's biologic medication that was recently approved for the treatment of moderate-to-severe p…

Read the full story

Tuesday, April 05, 2016

FDA Approves Inflectra, a Biosimilar to Remicade

And then there were two ... The U.S. Food and Drug Administration approved the biosimilar Inflectra (infliximab-dyyb) for multiple indications. Inflectra is biosimilar to Janssen Biotech, Inc.&rsqu…

Read the full story

Monday, March 28, 2016

More Than 1,000 Patients Join Corrona Psoriasis Registry

The Corrona Psoriasis Registry, a joint collaboration between the National Psoriasis Foundation (NPF) and Corrona, LLC, now includes more than 1,000 patients from 100 sites. Dermatologists assess r…

Read the full story
Load More